Simoons ML - Search Results

1

Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE).

Klootwijk P, Meij S, Melkert R, Lenderink T, Simoons ML. Klootwijk P, et al. Among authors: simoons ml. Circulation. 1998 Oct 6;98(14):1358-64. doi: 10.1161/01.cir.98.14.1358. Circulation. 1998. PMID: 9760288 Free article. Clinical Trial.

2

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.

Lenderink T, Simoons ML, Van Es GA, Van de Werf F, Verstraete M, Arnold AE. Lenderink T, et al. Among authors: simoons ml. Circulation. 1995 Sep 1;92(5):1110-6. doi: 10.1161/01.cir.92.5.1110. Circulation. 1995. PMID: 7648654 Clinical Trial.

3

Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina.

Klootwijk P, Meij S, von Es GA, Müller EJ, Umans VA, Lenderink T, Simoons ML. Klootwijk P, et al. Among authors: simoons ml. Eur Heart J. 1997 Jun;18(6):931-40. doi: 10.1093/oxfordjournals.eurheartj.a015381. Eur Heart J. 1997. PMID: 9183584 Free article. Clinical Trial.

4

Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.

Klootwijk P, Lenderink T, Meij S, Boersma H, Melkert R, Umans VA, Stibbe J, Müller EJ, Poortermans KJ, Deckers JW, Simoons ML. Klootwijk P, et al. Among authors: simoons ml. Eur Heart J. 1999 Aug;20(15):1101-11. doi: 10.1053/euhj.1999.1477. Eur Heart J. 1999. PMID: 10413640 Free article. Clinical Trial.

5

Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.

Akkerhuis KM, Maas AC, Klootwijk PA, Krucoff MW, Meij S, Califf RM, Simoons ML. Akkerhuis KM, et al. Among authors: simoons ml. J Electrocardiol. 2000 Apr;33(2):127-36. doi: 10.1016/s0022-0736(00)80069-2. J Electrocardiol. 2000. PMID: 10819406 Clinical Trial.

6

Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients.

Akkerhuis KM, Klootwijk PA, Lindeboom W, Umans VA, Meij S, Kint PP, Simoons ML. Akkerhuis KM, et al. Among authors: simoons ml. Eur Heart J. 2001 Nov;22(21):1997-2006. doi: 10.1053/euhj.2001.2750. Eur Heart J. 2001. PMID: 11603907

7

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.

Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML; CAPTURE Investigators. Lenderink T, et al. Among authors: simoons ml. Eur Heart J. 2003 Jan;24(1):77-85. doi: 10.1016/s0195-668x(02)00322-6. Eur Heart J. 2003. PMID: 12559939 Clinical Trial.

8

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.

Simoons ML, de Boer MJ, van den Brand MJ, van Miltenburg AJ, Hoorntje JC, Heyndrickx GR, van der Wieken LR, de Bono D, Rutsch W, Schaible TF, et al. Simoons ML, et al. Circulation. 1994 Feb;89(2):596-603. doi: 10.1161/01.cir.89.2.596. Circulation. 1994. PMID: 7508826 Clinical Trial.

9

Noninvasive assessment of reperfusion and reocclusion after thrombolysis in acute myocardial infarction.

Klootwijk P, Cobbaert C, Fioretti P, Kint PP, Simoons ML. Klootwijk P, et al. Among authors: simoons ml. Am J Cardiol. 1993 Dec 16;72(19):75G-84G. doi: 10.1016/0002-9149(93)90111-o. Am J Cardiol. 1993. PMID: 8279365 Review.

10

Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial.

Klootwijk P, Langer A, Meij S, Green C, Veldkamp RF, Ross AM, Armstrong PW, Simoons ML. Klootwijk P, et al. Among authors: simoons ml. Eur Heart J. 1996 May;17(5):689-98. doi: 10.1093/oxfordjournals.eurheartj.a014935. Eur Heart J. 1996. PMID: 8737099 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters